Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Shunxin Pharmaceutical is a specialized pharmaceutical manufacturing and development subsidiary of Chia Tai Tianqing Pharmaceutical Group (CTTQ), which is part of the Sino Biopharmaceutical conglomerate. Located in the Nanjing Jiangning Economic and Technological Development Zone, the company serves as a key production base for CTTQ's expanding portfolio of oncology and anti-infective therapies. The facility is designed to meet international GMP standards, supporting the large-scale manufacture of both small molecule drugs and advanced biologics. By leveraging the research and development capabilities of its parent company, Nanjing Shunxin plays a critical role in bringing innovative treatments for cancer and liver diseases to the Chinese and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongda Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical.